Literature DB >> 8411502

Ophthalmic examination among adults with diagnosed diabetes mellitus.

R J Brechner1, C C Cowie, L J Howie, W H Herman, J C Will, M I Harris.   

Abstract

OBJECTIVE: To assess whether adults with diagnosed diabetes in the United States are receiving recommended eye examinations for detection of diabetic retinopathy and what factors are associated with receiving them. DESIGN, SETTING, AND PARTICIPANTS: The design was a cross-sectional survey of the civilian, noninstitutionalized US population 18 years of age or older, based on the 1989 National Health Interview Survey. A multistage probability sampling strategy was used to identify a representative sample of 84,572 persons. A questionnaire on diabetes was administered to all subjects with diagnosed diabetes (n = 2405). MAIN OUTCOME MEASURE: A dilated eye examination in the past year. MAIN
RESULTS: Of all adults with diagnosed diabetes in the United States, only 49% had a dilated eye examination in the past year. This included 57% of people with insulin-dependent diabetes mellitus (IDDM), 55% with insulin-treated non-insulin-dependent diabetes mellitus (NIDDM), and 44% with NIDDM not treated with insulin. Even among diabetics at high risk of vision loss because of retinopathy or long duration of diabetes, the proportion with a dilated eye examination was only 61% and 57%, respectively. By logistic regression, the probability of a dilated eye examination among persons with NIDDM increased with older age, higher socioeconomic status, and having attended a diabetes education class. The probability of a dilated eye examination was not independently related to race, duration of diabetes, frequency of physician visits for diabetes, or health insurance.
CONCLUSIONS: About half of adults with diabetes in the United States are not receiving timely and recommended eye care to detect and treat retinopathy. Widespread interventions, including patient and professional education, are needed to ensure that diabetic patients who are not receiving appropriate eye care have an annual dilated eye examination to detect retinopathy and prevent vision loss.

Entities:  

Mesh:

Year:  1993        PMID: 8411502

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  52 in total

1.  Prevalence of self-rated visual impairment among adults with diabetes.

Authors:  J B Saaddine; K M Narayan; M M Engelgau; R E Aubert; R Klein; G L Beckles
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

2.  Relationship between compliance with ophthalmic examinations preoperatively and visual outcome after vitrectomy for proliferative diabetic retinopathy.

Authors:  Machiko Itoh-Tanimura; Akito Hirakata; Yuji Itoh; Milena Eimi Sano; Makoto Inoue; Hitoshi Ishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-06       Impact factor: 2.447

3.  Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women.

Authors:  Yanping Li; Yang Hu; Sylvia H Ley; Swapnil Rajpathak; Frank B Hu
Journal:  Diabetes Care       Date:  2014-08-22       Impact factor: 19.112

4.  How good is the quality of health care in the United States? 1998.

Authors:  Mark A Schuster; Elizabeth A McGlynn; Robert H Brook
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

5.  Can America's urban safety net systems be a solution to unequal treatment?

Authors:  Sheri L Eisert; Philip S Mehler; Patricia A Gabow
Journal:  J Urban Health       Date:  2008-06-14       Impact factor: 3.671

6.  The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.

Authors:  Mary Gilbert Lawrence
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Machine Learning Approaches for Detecting Diabetic Retinopathy from Clinical and Public Health Records.

Authors:  Omolola Ogunyemi; Dulcie Kermah
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

8.  Teleretinal screening for diabetic retinopathy in six Los Angeles urban safety-net clinics: final study results.

Authors:  Omolola Ogunyemi; Sheba George; Lauren Patty; Senait Teklehaimanot; Richard Baker
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

9.  Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis.

Authors:  David Maberley; Hugh Walker; Anita Koushik; Alan Cruess
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

Review 10.  Ocular disease, knowledge and technology applications in patients with diabetes.

Authors:  Jennifer Threatt; Jennifer F Williamson; Kyle Huynh; Richard M Davis; Kathie Hermayer
Journal:  Am J Med Sci       Date:  2013-04       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.